Fernanda Arnaldez Email and Phone Number
Fernanda Arnaldez work email
- Valid
- Valid
- Valid
- Valid
Fernanda Arnaldez personal email
- Valid
Fernanda Arnaldez phone numbers
Experienced pharmaceutical executive and savvy physician-scientist with over twenty years of experience in oncology and rare diseases drug development, from discovery to approval and launch. I can successfully work in diverse environments (academia, big pharma, Government, biotechnology); with demonstrated cultural awareness leading global teams, including Americas, Europe, and APAC. I am a strong and influential leader, with an unobstructed vision and a strategic mindset. I find joy in building high-performing teams anchored by trust and flexibility; ensuring talent at all levels is recognized and given the opportunity to gain experience and succeed.I prefer to lead by influence by communicating openly and effectively with internal and external stakeholders.My passion is advancing the science and practice of oncology by bringing novel and effective therapies to patients in need. I leverage my credentials, as well as my expertise in oncology clinical development, biomarker development, immunology, and molecular oncology, to drive excellence and innovation in oncology R&D. I am also enthusiastic about supporting the professional development of the next generation of oncology leaders, as evidenced by my involvement in various advisory boards, networks, and publications.
Astrazeneca
View- Website:
- astrazeneca.com
- Employees:
- 78605
-
Executive Medical Director And Global Product Leader - Oncology Research And DevelopmentAstrazenecaWashington, Dc, Us -
Executive Medical Director / Global Product Leader - Oncology Research & DevelopmentAstrazeneca Jul 2021 - PresentCambridge, Cambridgeshire, GbMy teams are responsible for the development of immunotherapy biologics, T-cell engagers, small molecules, cell therapy and antibody-drug conjugate assets within the Early Oncology Research and Development Organization, from candidate lead selection to phase III-enabling clinical trials. I am responsible and accountable for strategy, development and execution of the portfolio across multiple line functions. -
Senior Medical Director/Global Product Leader - Early Development Oncology R&DAstrazeneca Apr 2021 - Jul 2021Cambridge, Cambridgeshire, GbI lead a group within the Early Oncology R&D organization that is responsible for the development (lead selection to phase III enabling studies) of Immunotherapy, Cell Therapy and ADC early assets. I am responsible and accountable for strategy, development and execution of the portfolio across line functions. -
Strategic Advisory BoardOsteosarcoma Institute Dec 2020 - PresentDallas, Texas, UsThe Osteosarcoma Institute (OSI) is a 501(c)(3) public, non-operating foundation, with the mission of identifying and funding most promising and breakthrough osteosarcoma clinical trials and science. -
Chief, Washington Dc Founding MemberChief Jun 2021 - Oct 2024New York, Ny, UsChief is a private network built to drive more women into positions of power and keep them there. Chief is the only organization specifically designed for senior women leaders to strengthen their leadership journey, cross-pollinate ideas across industries, and effect change from the top-down. -
Member Of The Board Of Advisors - UsgUniversity System Of Maryland Sep 2021 - Sep 2024Baltimore, Maryland, UsJuly 2023 - Aug 2024 : Vice Chair, Executive CommitteeThe Board of Advisors provides valuable advice and support to the campus leadership and to University System of Maryland, in order to succeed in its mission and grow in its ability to serve students and the community. -
Executive Medical Director, Global Clinical DevelopmentMacrogenics, Inc. Apr 2019 - Apr 2021Rockville, Md, UsAs Executive Medical Director, accountable to the CMO, I provided leadership and medical support to meet the company strategic goals, establishing critical cross-functional relationships with diverse line functions including Regulatory Affairs, Clinical Operations and CROs, Biostatistics/Data Management, R&D and others. - Global Program Leader, Breast Cancer anti-HER-2 franchise (Fc-optimized mAb); leading to the regulatory approval of Margenza (margetuximab) in December 2020 and commercial launch in March 2021.- Global Program Leader, B7-H3 Franchise (Fc-Optimized mAbs, mAbs, bi-specifics, ADCs) - including partnerships with Asia-Pacific industry collaboratorsDesign, development and implementation of clinical studies from first in human through proof of concept and pivotal/registrational trials, regulatory interactions, stakeholder management. -
Scientific Officer, Experimental Therapeutics Clinical Trials NetworkNational Cancer Institute (Nci) Jun 2018 - May 2020Bethesda, Md, UsAs its Scientific Officer, I held the responsibility of portfolio management, operations, grants and contracts of a complex infrastructure of more than forty high-performing North American sites that form the Experimental Therapeutics Clinical Trials Network (ETCTN).The objectives of the ETCTN are to:• Conduct clinical trials of NCI-IND agents in high priority areas of unmet medical needs• Ensure efficient and timely activation and conduct of these clinical trials• Integrate preclinical findings using clinical samples for biomarker analysis• Promote collaboration among institutions and investigators• Integrate molecular characterization, pharmacology, cancer biology, and imaging into clinical trials -
Associate Research Physician -- Center For Cancer ResearchNational Cancer Institute (Nci) May 2016 - May 2020Bethesda, Md, Us-Designed and implemented innovative clinical trials, with the goal of improving outcomes for children, adolescents and young adults with solid tumors and genetic tumor predisposition syndromes. -Led care of high-acuity oncology patients receiving state-of-the-art therapies, including stem cell transplant, cell therapies (CAR-T cells, NK-cell based therapies, modified TCRs), anti-tumor vaccines, immunotherapy, targeted chemotherapy and others. - Director, NIH Pediatric and Wild-Type GIST Program -
Senior Investigator, Cancer Therapy Evaluation Program (Ctep), NciNational Cancer Institute (Nci) May 2016 - Jun 2019Bethesda, Md, UsThe Cancer Therapy Evaluation Program (CTEP) coordinates the clinical therapeutics development program of the Division of Cancer Treatment and Diagnosis (DCTD), NCI. -Led and coordinated a vast national network of 12 Lead Academic NCI-designated cancer centers and 41 organizations; coordinating multiple stakeholders: pharmaceutical collaborators, biotechnology companies, Government agencies and academic organizations-Chair, NCI Community Oncology Research Program (NCORP) Tissue Procurement Study - Cancer Moonshot Initiative-Program Director, Experimental Therapeutics Clinical Trials Network (ETCTN)-Protocol Review Committee, CTEP -
Visiting Physician Cancer Therapy Evaluation Program (Ctep)National Cancer Institute (Nci) Nov 2016 - Dec 2016Bethesda, Md, Us -
Global Clinical Leader / Medical Director - Oncology Global DevelopmentNovartis Pharmaceuticals Corporation Mar 2016 - May 2016Basel, Baselstadt, ChGlobal Medical Lead, Registrational Phase III Study, Pasireotide (leading to approval) -
Medical Science Expert - Oncology Global DevelopmentNovartis Pharmaceuticals Corporation Sep 2014 - Mar 2016Basel, Baselstadt, Ch -
Assistant Clinical Investigator - Center For Cancer ResearchNational Cancer Institute (Nci) Jun 2012 - Sep 2014Bethesda, Md, UsDesigned and led the first clinical trial exploiting the unique biology of SDH deficient /wild-type gastrointestinal stromal tumors Delivered state-of the-art clinical care to high-acuity patients on experimental therapies, such as gene therapy, cell therapy, and drugs in a first-in-human contextContributed to physician education programs.In my laboratory, I led cross-functional programs with the goal of applying biological discoveries in rhabdomyosarcoma and Ewing’s sarcoma to therapeutic target and compound selection. This included but was not limited to loss-of-function high throughput screening, functional genomics and chemical screens. -
Advanced Solid Tumor Oncology Program Fellow -- Pediatric Oncology BranchNational Cancer Institute (Nci) Jul 2011 - Jun 2012Bethesda, Md, Us -
Chief Fellow, Pediatric Hematology-OncologyNational Cancer Institute (Nci) Jul 2010 - Jul 2011Bethesda, Md, Us -
Clinical FellowJohns Hopkins University/National Cancer Institute-Nih Jul 2008 - Jul 2011Baltimore, Md, UsPediatric Hematology-Oncology Fellow and Chief FellowJohns Hopkins University/National Cancer Institute- National Institutes of Health -
PhysicianUpmc Children'S Hospital Of Pittsburgh Jun 2005 - Jun 2008Pittsburgh, Pennsylvania, UsPediatric Residency Program
Fernanda Arnaldez Skills
Fernanda Arnaldez Education Details
-
University Of Buenos AiresMedicine -
Rutgers Business SchoolMba: Biopharma Innovation -
National Institutes Of HealthSenior Leadership Program - Dhhs -
Columbia Business SchoolAnd Digital Health -
Massachusetts Institute Of TechnologyFinance And Macroeconomics
Frequently Asked Questions about Fernanda Arnaldez
What company does Fernanda Arnaldez work for?
Fernanda Arnaldez works for Astrazeneca
What is Fernanda Arnaldez's role at the current company?
Fernanda Arnaldez's current role is Executive Medical Director and Global Product Leader - Oncology Research and Development.
What is Fernanda Arnaldez's email address?
Fernanda Arnaldez's email address is fa****@****ail.com
What is Fernanda Arnaldez's direct phone number?
Fernanda Arnaldez's direct phone number is +130145*****
What schools did Fernanda Arnaldez attend?
Fernanda Arnaldez attended University Of Buenos Aires, Rutgers Business School, National Institutes Of Health, Columbia Business School, Massachusetts Institute Of Technology.
What skills is Fernanda Arnaldez known for?
Fernanda Arnaldez has skills like Cancer, Oncology, Clinical Research, Pediatrics, Clinical Trials, Medicine, Medical Education, Medical Research, Pediatric Oncology, Molecular Oncology, Experimental Therapeutics, Molecular Biology.
Who are Fernanda Arnaldez's colleagues?
Fernanda Arnaldez's colleagues are Stefan Molitschnig, Mariano Romero, Jacqui Edwards, Weixia Wang, Charlotte Crawford, 戴雪松, Mariah Goodwyn.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial